4
MARKET OVERVIEW
Telehealth's rise reshapes patient care, yet privacy and interoperability hurdles persist.
55
4.2.1.1
INCREASING ADOPTION OF TELEHEALTH AND REMOTE CARE
4.2.1.2
INCREASING SMARTPHONE USE AND DIGITAL COMFORT
4.2.1.3
IMPLEMENTATION OF GOVERNMENT REGULATIONS AND INITIATIVES TO PROMOTE PATIENT-CENTRIC CARE
4.2.1.4
GROWING PREVALENCE OF CHRONIC DISEASES AND RISING DEMAND FOR LONG-TERM PATIENT INVOLVEMENT
4.2.2.1
DATA PRIVACY AND CYBERSECURITY CONCERNS
4.2.2.2
INADEQUATE INTEROPERABILITY ACROSS HEALTHCARE PROVIDERS
4.2.2.3
SHORTAGE OF SKILLED IT PROFESSIONALS IN HEALTHCARE INDUSTRY
4.2.3.1
EXPANSION OF REMOTE AND HOME-BASED CARE MODELS
4.2.3.2
AI-DRIVEN PERSONALIZATION IN PATIENT ENGAGEMENT SOLUTIONS
4.2.3.3
INTEGRATION WITH WEARABLES AND PERSONALIZED HEALTH TECH
4.2.4.1
LOW PATIENT ADOPTION AND ENGAGEMENT OVER TIME
4.2.4.2
FRAGMENTED DATA AND SILOED DIGITAL TOOLS
4.3
UNMET NEEDS & WHITE SPACES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive pressures and seize opportunities in the evolving global healthcare IT landscape.
63
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
BARGAINING POWER OF SUPPLIERS
5.1.2
BARGAINING POWER OF BUYERS
5.1.3
THREAT OF SUBSTITUTES
5.1.4
THREAT OF NEW ENTRANTS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMICS OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.5.1
INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY COMPONENT, 2025
5.5.2
INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY REGION, 2025
5.6.1
IMPORT SCENARIO FOR HS CODE 8528, 2021–2024
5.6.2
IMPORT SCENARIO FOR HS CODE 8471, 2021–2024
5.6.3
EXPORT SCENARIO FOR HS CODE 8528, 2021–2024
5.6.4
EXPORT SCENARIO FOR HS CODE 8471, 2021–2024
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.9
INVESTMENT & FUNDING SCENARIO
5.10.1
ACHIEVING USD 15 MILLION IN SAVINGS BY REDUCING READMISSIONS WITH POST-DISCHARGE FOLLOW-UP
5.10.2
BUILD TRUST THROUGH PATIENT ENGAGEMENT TECHNOLOGY: CHILDREN’S HOSPITAL CASE STUDY
5.10.3
IMPROVING PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL WITH TRUBRIDGE PATIENT CONNECT
5.11
IMPACT OF 2025 US TARIFF ON PATIENT ENGAGEMENT SOLUTIONS MARKET
5.11.2
PRICE IMPACT ANALYSIS
5.11.3
IMPACT ON COUNTRY/REGION
5.11.4
IMPACT ON END-USE INDUSTRIES
5.11.4.1
HOSPITALS AND HEALTHCARE SYSTEMS
5.11.4.2
ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
5.11.4.3
HOME HEALTHCARE PROVIDERS
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS
Harness AI and emerging tech to revolutionize patient engagement and healthcare delivery.
82
6.1
KEY EMERGING TECHNOLOGIES
6.1.2
API & EHR INTEGRATION TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML)
6.2.2
CONVERSATIONAL AI/CHATBOTS
6.2.3
BEHAVIORAL ANALYTICS AND PERSONALIZATION ENGINES
6.3
ADJACENT TECHNOLOGIES
6.3.1
CYBERSECURITY AND DATA ENCRYPTION
6.3.3
BIG DATA AND ADVANCED ANALYTICS
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.5.1
PATENT PUBLICATION TRENDS FOR PATIENT ENGAGEMENT SOLUTION
6.5.2
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.5.3
LIST OF PATENTS/PATENT APPLICATIONS
6.6.1
AI-DRIVEN PREDICTIVE ENGAGEMENT
6.6.2
CONTINUOUS REMOTE CARE AND HOSPITAL-AT-HOME ENABLEMENT
6.6.3
PERSONALIZED DIGITAL THERAPEUTICS AND BEHAVIORAL COACHING
6.6.4
CLOSED-LOOP CARE COORDINATION AND VALUE-BASED PERFORMANCE OPTIMIZATION
6.6.5
DECENTRALIZED CLINICAL TRIALS AND REAL-WORLD EVIDENCE GENERATION
6.7
IMPACT OF AI/GEN AI ON PATIENT ENGAGEMENT SOLUTIONS MARKET
6.7.2
MARKET POTENTIAL OF AI/GEN AI IN PATIENT ENGAGEMENT SOLUTIONS MARKET
6.7.3
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
6.7.3.1
AI-DRIVEN CONVERSATIONAL AI FOR PRE/POST-OP ENGAGEMENT
6.7.4
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
6.7.4.1
PATIENT COMMUNICATION & VIRTUAL CARE PLATFORMS
6.7.4.2
REMOTE PATIENT MONITORING & DIGITAL THERAPEUTICS
6.7.4.3
POPULATION HEALTH & HEALTH EQUITY PROGRAMS
6.7.5
USER READINESS AND IMPACT ASSESSMENT
6.7.5.1.1
USER A: HOSPITALS & CLINICS
6.7.5.1.2
USER B: HEALTHCARE PROVIDERS, EMPLOYERS, AND FORENSIC AGENCIES
6.7.5.2
IMPACT ASSESSMENT
6.7.5.2.1
USER A: CLINICAL, REFERENCE, AND TOXICOLOGY LABORATORIES
6.7.5.2.2
USER B: HEALTHCARE PROVIDERS, EMPLOYERS, AND FORENSIC AGENCIES
7
REGULATORY LANDSCAPE
Navigate complex global regulations with insights into regional compliance and industry standards.
96
7.1
REGIONAL REGULATIONS & COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2
REGULATORY FRAMEWORK
7.1.2.5
MIDDLE EAST & AFRICA
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Identify key decision influencers and unmet needs shaping buyer behavior in patient engagement solutions.
105
8.2
DECISION-MAKING PROCESS
8.3
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5
UNMET NEEDS/END-USER EXPECTATIONS
8.5.2
END-USER EXPECTATIONS
9
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 20 Data Tables
111
9.2.1
IN-ROOM TELEVISIONS
9.2.1.1
RISING PATIENT DEMAND FOR REAL-TIME HEALTH TRANSPARENCY AND SMART ROOM MODERNIZATION INITIATIVES TO DRIVE MARKET
9.2.2
INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES
9.2.2.1
HOSPITALS TO INCREASINGLY ADOPT BEDSIDE TERMINALS TO ADDRESS WORKFORCE SHORTAGES AND REDUCE NURSING WORKLOAD
9.2.3.1
STRONG ROI PROFILE, LOWER UPFRONT INVESTMENT, AND RAPID ROLLOUT CAPABILITY TO PROPEL MARKET GROWTH
9.3.1
PRE-CARE ENGAGEMENT
9.3.1.1
INCREASING ADOPTION OF CONSUMER-CENTRIC ACCESS MODELS TO AID SEGMENT GROWTH
9.3.2
POINT-OF-CARE ENGAGEMENT
9.3.2.1
EXPONENTIAL GROWTH IN HEALTHCARE DATA AND RISING INFORMATION COMPLEXITY TO AUGMENT SEGMENT GROWTH
9.3.3
POST-CARE ENGAGEMENT
9.3.3.1
SHIFT TOWARD VALUE-BASED CARE AND REIMBURSEMENT MODELS FOR READMISSION RATES TO DRIVE SEGMENT GROWTH
9.4.1
IMPLEMENTATION & INTEGRATION SERVICES
9.4.1.1
NEED FOR EXPERTISE TO OPERATIONALIZE SOPHISTICATED PATIENT ENGAGEMENT ECOSYSTEMS TO FUEL MARKET GROWTH
9.4.2
TRAINING & EDUCATION SERVICES
9.4.2.1
NEED TO ERADICATE MEASURABLE STAFF USABILITY CHALLENGES AND PATIENT DIGITAL ACCESS GAPS TO DRIVE SEGMENT
9.4.3
SUPPORT & MAINTENANCE SERVICES
9.4.3.1
DEPENDENCY ON PATIENT PORTALS, TELEHEALTH SYSTEMS, AND INTEGRATED EHR INFRASTRUCTURES TO AID MARKET GROWTH
9.4.4
CONSULTING SERVICES
9.4.4.1
SHIFT FROM VOLUME-BASED TO VALUE-BASED CARE MODELS TO DRIVE CONSULTING SERVICES MARKET
10
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 5 Data Tables
126
10.2.1
ON-PREMISES ADOPTION TO ACCELERATE AMID SECURITY, REGULATORY, AND INTEGRATION PRIORITIES
10.3.1
CLOUD-BASED PATIENT ENGAGEMENT TO PROPEL SCALABLE, SECURE, AND INTEROPERABLE CARE
11
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 13 Data Tables
130
11.2.1
VALUE-BASED CARE MODELS AND TELEHEALTH EXPANSION TO PROPEL CLINICAL CARE SEGMENT
11.3
CARE COORDINATION & COMMUNICATION
11.3.1
FRAGMENTED CARE PATHWAYS AND INTEROPERABILITY MANDATES TO ACCELERATE MARKET GROWTH
11.4.1
HOSPITAL-AT-HOME EXPANSION, READMISSION PENALTIES, AND RPM REIMBURSEMENT TO FUEL SEGMENT GROWTH
11.5
POPULATION HEALTH & BEHAVIORAL ENGAGEMENT
11.5.1
VALUE-BASED CARE MANDATES, RISK STRATIFICATION, AND BEHAVIORAL HEALTH INTEGRATION TO PROPEL SEGMENT GROWTH
11.6
FINANCIAL ENGAGEMENT
11.6.1
RISING OUT-OF-POCKET COSTS, CONSUMERISM, AND REVENUE PRESSURE TO DRIVE FINANCIAL ENGAGEMENT ADOPTION
12
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 16 Data Tables
139
12.2.1
CARDIOVASCULAR DISEASES
12.2.1.1
NEED FOR CONTINUOUS MONITORING AND PREVENTIVE ENGAGEMENT THROUGH DIGITAL HEALTH PLATFORMS TO DRIVE MARKET
12.2.2.1
CONTINUOUS GLUCOSE MONITORING, BEHAVIORAL ADHERENCE, AND DATA-DRIVEN SELF-MANAGEMENT THROUGH DIGITAL ENGAGEMENT TO DRIVE MARKET
12.2.3.1
PREVENTIVE ENGAGEMENT, BEHAVIORAL MODIFICATION, AND LONG-TERM RISK REDUCTION THROUGH DIGITAL HEALTH PLATFORMS TO DRIVE MARKET
12.2.4
RESPIRATORY DISORDERS
12.2.4.1
ADVANCING CONTINUOUS SYMPTOM MONITORING AND PREVENTIVE CARE THROUGH DIGITAL ENGAGEMENT PLATFORMS TO FUEL MARKET GROWTH
12.2.5.1
LONGITUDINAL CARE COORDINATION, SYMPTOM MONITORING, AND SURVIVORSHIP ENGAGEMENT TO BOOST MARKET
12.2.6
OTHER CHRONIC DISEASES
12.3.1
PREVENTIVE SCREENING, REPRODUCTIVE CARE COORDINATION, AND LIFECYCLE ENGAGEMENT TO AID MARKET GROWTH
12.4
BEHAVIORAL & MENTAL HEALTH
12.4.1
INCREASING GLOBAL PREVALENCE OF DEPRESSION, ANXIETY, SUBSTANCE USE DISORDERS TO AID MARKET GROWTH
12.5
OTHER THERAPEUTIC AREAS
13
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
151
13.2
PATIENT/CLIENT SCHEDULING
13.2.1
DIGITAL-FIRST, MOBILE-DRIVEN SCHEDULING TO REDUCE NO-SHOWS AND STRENGTHEN ACCESS PERFORMANCE
13.3.1
TELEHEALTH TO DRIVE QUALITY IMPROVEMENT AND HYBRID CARE DELIVERY GROWTH
13.4.1
E-PRESCRIBING TO STRENGTHEN MEDICATION SAFETY REGULATORY COMPLIANCE
13.5.1
DIGITAL RECORD ACCESS TO DRIVE DOCUMENT MANAGEMENT IN CORE PATIENT ENGAGEMENT INFRASTRUCTURE
13.6.1
RISING PATIENT FINANCIAL RESPONSIBILITY AND GROWING DEMAND FOR DIGITAL TRANSPARENCY TO DRIVE MARKET
13.7.1
SELF-DIRECTED HEALTH RESEARCH AND DIGITAL LITERACY GAPS TO RISE DEMAND FOR INTEGRATED PATIENT EDUCATION TOOLS
13.8
OTHER FUNCTIONALITIES
14
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
160
14.2.1
HOSPITALS & HEALTHCARE SYSTEMS
14.2.1.1
HEALTHCARE SYSTEMS TO DRIVE PATIENT EXPERIENCE AND OPERATIONAL EFFICIENCY THROUGH INTEGRATED PATIENT ENGAGEMENT SOLUTIONS
14.2.2
ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
14.2.2.1
NEED FOR OPTIMIZING PATIENT ACCESS AND ENGAGEMENT IN OUTPATIENT CARE SETTINGS TO PROPEL SEGMENT GROWTH
14.2.3
HOME HEALTHCARE PROVIDERS
14.2.3.1
HOME HEALTHCARE PROVIDES TO ENHANCE PATIENT ENGAGEMENT AND REMOTE CARE DELIVERY IN HOME SETTINGS
14.3.1.1
PRIVATE PAYERS TO ENHANCE MEMBER EXPERIENCE AND COST EFFICIENCY THROUGH DIGITAL-FIRST ENGAGEMENT STRATEGIES
14.3.2.1
PUBLIC PAYERS TO STRENGTHEN POPULATION HEALTH MANAGEMENT THROUGH INCLUSIVE AND SCALABLE DIGITAL ENGAGEMENT
15
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 17 Countries | 348 Data Tables.
169
15.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
15.2.2.1
VALUE-BASED CARE REFORMS AND LONG-TERM CARE MANAGEMENT NEED TO ACCELERATE MARKET GROWTH
15.2.3.1
GOVERNMENT POLICIES TO STRENGTHEN DIGITAL HEALTH INFRASTRUCTURE AND INTEROPERABILITY
15.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
15.3.2.1
NATIONWIDE EPA ROLLOUT AND DIGITAL THERAPEUTICS LEADERSHIP TO PROPEL MARKET GROWTH
15.3.3.1
NEAR-UNIVERSAL DIGITAL HEALTH RECORD ADOPTION AND STRATEGIC INVESTMENT TO AID MARKET GROWTH
15.3.4.1
NHS APP SCALE-UP AND VIRTUAL CARE EXPANSION TO BOOST MARKET GROWTH
15.3.5.1
RISING DIGITAL HEALTH INVESTMENT AND GROWING FOCUS ON NATIONAL TELEMEDICINE INFRASTRUCTURE TO FUEL MARKET GROWTH
15.3.6.1
RISING TELEMEDICINE EXPANSION AND GROWING MHEALTH ADOPTION TO STRENGTHEN MARKET
15.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
15.4.2.1
HIGH DIGITAL HEALTH ADOPTION AND INTERNET HOSPITAL EXPANSION TO ACCELERATE MARKET GROWTH
15.4.3.1
HEALTHCARE DIGITALIZATION TO ACCELERATE PATIENT ENGAGEMENT IN JAPAN
15.4.4.1
DIGITAL PUBLIC HEALTH INFRASTRUCTURE AND MOBILE PENETRATION TO AUGMENT MARKET GROWTH
15.4.5.1
NATIONAL DIGITAL INTEGRATION AND RAPID POPULATION AGING TO AID MARKET GROWTH
15.4.6.1
NEAR-UNIVERSAL DIGITAL RECORDS AND EMBEDDED TELEHEALTH ADOPTION TO FUEL MARKET GROWTH
15.4.7
REST OF ASIA PACIFIC
15.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
15.5.2.1
GOVERNMENT-LED TELEHEALTH SCALE AND INSTITUTIONALIZED PATIENT PARTICIPATION TO PROPEL DIGITAL ENGAGEMENT
15.5.3.1
STRUCTURAL HEALTH SYSTEM GAPS TO SPUR DIGITAL PATIENT ENGAGEMENT ADOPTION
15.5.4
REST OF LATIN AMERICA
15.6
MIDDLE EAST & AFRICA
15.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
15.6.2.1
HIGH NCD BURDEN AND GOVERNMENT-OWNED DIGITAL PLATFORMS TO AUGMENT PATIENT ENGAGEMENT
15.6.2.2
KINGDOM OF SAUDI ARABIA
15.6.2.2.1
GOVERNMENT-LED DIGITAL HEALTH INNOVATIONS TO ACCELERATE PATIENT ENGAGEMENT
15.6.2.3.1
PROGRESSIVE DIGITAL HEALTH INNOVATIONS TO STRENGTHEN UAE PATIENT ENGAGEMENT SOLUTIONS MARKET
15.6.2.4
REST OF GCC COUNTRIES
15.6.3.1
MASSIVE TELEMEDICINE ADOPTION AND INNOVATIVE DIGITAL PLATFORMS TO AID MARKET GROWTH
15.6.4
REST OF MIDDLE EAST & AFRICA
16
COMPETITIVE LANDSCAPE
Discover how top players dominate patient engagement with strategic innovations and market leadership.
320
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
16.2.1
OVERVIEW OF KEY STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
16.3
REVENUE ANALYSIS, 2020–2024
16.4
MARKET SHARE ANALYSIS, 2024
16.6
COMPANY VALUATION & FINANCIAL METRICS
16.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
16.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.7.5.1
COMPANY FOOTPRINT
16.7.5.2
REGION FOOTPRINT
16.7.5.3
COMPONENT FOOTPRINT
16.7.5.4
APPLICATION FOOTPRINT
16.7.5.5
END-USER FOOTPRINT
16.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
16.8.1
PROGRESSIVE COMPANIES
16.8.2
RESPONSIVE COMPANIES
16.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
16.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
16.8.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
16.9
COMPETITIVE SCENARIO
16.9.1
PRODUCT LAUNCHES & ENHANCEMENTS
16.9.4
OTHER DEVELOPMENTS
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
339
17.1.1
MCKESSON CORPORATION
17.1.1.1
BUSINESS OVERVIEW
17.1.1.2
PRODUCTS OFFERED
17.1.1.3
RECENT DEVELOPMENTS
17.1.1.4.2
STRATEGIC CHOICES
17.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
17.1.3
MICROSOFT (NUANCE COMMUNICATIONS, INC.)
17.1.8
GETWELLNETWORK, INC.
17.1.11
ONEVIEW HEALTHCARE
17.1.13
EPIC SYSTEMS CORPORATION
17.1.14
HARRIS HEALTHCARE
17.1.15
MEDICAL INFORMATION TECHNOLOGY, INC.
17.1.16
TEBRA TECHNOLOGIES, INC.
17.1.18
SOLUTIONREACH, INC.
17.1.19
EXPERIAN INFORMATION SOLUTIONS, INC.
18
RESEARCH METHODOLOGY
403
18.1.1
SECONDARY RESEARCH
18.1.1.1
KEY SECONDARY SOURCES
18.1.1.2
KEY DATA FROM SECONDARY SOURCES
18.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
18.1.2.3
KEY DATA FROM PRIMARY SOURCES
18.1.2.4
BREAKDOWN OF PRIMARIES
18.1.2.5
INSIGHTS FROM PRIMARY EXPERTS
18.2
RESEARCH METHODOLOGY DESIGN
18.3
MARKET SIZE ESTIMATION
18.3.1
BOTTOM-UP APPROACH (REVENUE SHARE ANALYSIS)
18.3.2
TOP-DOWN OF PARENT MARKET ASSESSMENT
18.3.3
PRIMARY INTERVIEWS
18.5
MARKET SHARE ESTIMATION
18.7
RESEARCH LIMITATIONS
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
TABLE 1
PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3
IMPACT OF PORTER’S FIVE FORCES ON PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 4
ROLE OF COMPANIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET ECOSYSTEM
INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY COMPONENT,
INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY REGION,
TABLE 7
IMPORT SCENARIO FOR HS CODE 8528, 2021–2024 (USD THOUSAND)
TABLE 8
IMPORT SCENARIO FOR HS CODE 8741, 2021–2024 (USD THOUSAND)
TABLE 9
EXPORT SCENARIO FOR HS CODE 8528, 2021–2024 (USD THOUSAND)
TABLE 10
EXPORT SCENARIO FOR HS CODE 8471, 2021–2024 (USD THOUSAND)
TABLE 11
LIST OF KEY CONFERENCES AND EVENTS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, JANUARY 2026–DECEMBER 2027
TABLE 12
CASE STUDY 1: ACHIEVING USD 15 MILLION IN SAVINGS BY REDUCING READMISSIONS WITH POST-DISCHARGE FOLLOW-UP
TABLE 13
CASE STUDY 2: BUILD TRUST THROUGH PATIENT ENGAGEMENT TECHNOLOGY: A CHILDREN’S HOSPITAL CASE STUDY
TABLE 14
CASE STUDY 3: IMPROVING PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL WITH TRUBRIDGE PATIENT CONNECT
TABLE 15
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 16
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 17
LIST OF PATENTS/PATENT APPLICATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 18
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
REGULATORY SCENARIO OF NORTH AMERICA
TABLE 24
REGULATORY SCENARIO OF EUROPE
TABLE 25
REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 26
REGULATORY SCENARIO OF LATIN AMERICA
TABLE 27
REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 28
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF MAJOR END USERS (%)
TABLE 29
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 30
UNMET NEEDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 31
END-USER EXPECTATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 32
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 33
LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT HARDWARE MARKET
TABLE 34
PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 35
PATIENT ENGAGEMENT HARDWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 36
PATIENT ENGAGEMENT HARDWARE MARKET FOR IN-ROOM TELEVISIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 37
PATIENT ENGAGEMENT HARDWARE MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 38
PATIENT ENGAGEMENT HARDWARE MARKET FOR TABLETS, BY REGION, 2024–2031 (USD MILLION)
TABLE 39
LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOFTWARE MARKET
TABLE 40
PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 41
PATIENT ENGAGEMENT SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 42
PATIENT ENGAGEMENT SOFTWARE MARKET FOR PRE-CARE ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 43
PATIENT ENGAGEMENT SOFTWARE MARKET FOR POINT-OF-CARE ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 44
PATIENT ENGAGEMENT SOFTWARE MARKET FOR POST-CARE ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 45
LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT SERVICES MARKET
TABLE 46
PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 47
PATIENT ENGAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 48
PATIENT ENGAGEMENT SERVICES MARKET FOR IMPLEMENTATION & INTEGRATION SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 49
PATIENT ENGAGEMENT SERVICES MARKET FOR TRAINING & EDUCATION SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 50
PATIENT ENGAGEMENT SERVICES MARKET FOR SUPPORT & MAINTENANCE SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 51
PATIENT ENGAGEMENT SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 52
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 53
KEY COMPANIES OFFERING ON-PREMISES PATIENT ENGAGEMENT SOLUTIONS
TABLE 54
ON-PREMISES PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 55
KEY COMPANIES OFFERING CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS
TABLE 56
CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 57
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 58
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CLINICAL CARE
TABLE 59
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLINICAL CARE, BY REGION, 2024–2031 (USD MILLION)
TABLE 60
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CARE COORDINATION & COMMUNICATION
TABLE 61
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARE COORDINATION & COMMUNICATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 62
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR HOME & REMOTE CARE
TABLE 63
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME & REMOTE CARE, BY REGION, 2024–2031 (USD MILLION)
TABLE 64
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR POPULATION HEALTH & BEHAVIORAL ENGAGEMENT
TABLE 65
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR POPULATION HEALTH & BEHAVIORAL ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 66
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR FINANCIAL ENGAGEMENT
TABLE 67
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 68
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER APPLICATIONS
TABLE 69
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 70
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 71
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CHRONIC DISEASES
TABLE 72
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 73
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 74
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 75
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2024–2031 (USD MILLION)
TABLE 76
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2024–2031 (USD MILLION)
TABLE 77
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 78
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ONCOLOGY, BY REGION, 2024–2031 (USD MILLION)
TABLE 79
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 80
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR WOMEN’S HEALTH
TABLE 81
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY REGION, 2024–2031 (USD MILLION)
TABLE 82
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR BEHAVIORAL & MENTAL HEALTH
TABLE 83
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BEHAVIORAL & MENTAL HEALTH, BY REGION, 2024–2031 (USD MILLION)
TABLE 84
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER THERAPEUTIC AREAS
TABLE 85
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2024–2031 (USD MILLION)
TABLE 86
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 87
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR PATIENT/CLIENT SCHEDULING
TABLE 88
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2024–2031 (USD MILLION)
TABLE 89
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR TELEHEALTH
TABLE 90
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY REGION, 2024–2031 (USD MILLION)
TABLE 91
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR E-PRESCRIBING
TABLE 92
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2024–2031 (USD MILLION)
TABLE 93
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR DOCUMENT MANAGEMENT
TABLE 94
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 95
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR BILLING & PAYMENTS
TABLE 96
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 97
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR PATIENT EDUCATION
TABLE 98
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 99
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER FUNCTIONALITIES
TABLE 100
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 101
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 102
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO PAYERS
TABLE 103
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 105
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
TABLE 106
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2024–2031 (USD MILLION)
TABLE 107
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 108
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 109
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO PAYERS
TABLE 110
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 112
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 113
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 114
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO OTHER END USERS
TABLE 115
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 116
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 117
NORTH AMERICA: KEY MACROINDICATORS
TABLE 118
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 120
NORTH AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121
NORTH AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122
NORTH AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 123
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 124
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 125
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 126
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 127
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 128
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 129
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 132
US: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133
US: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134
US: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 136
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 137
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 138
US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 140
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 141
US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142
US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 143
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 144
CANADA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145
CANADA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146
CANADA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 148
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 149
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 150
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 152
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 153
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 155
EUROPE: KEY MACROINDICATORS
TABLE 156
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 158
EUROPE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 159
EUROPE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160
EUROPE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 162
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 163
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 164
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 166
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 167
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 170
GERMANY: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171
GERMANY: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 172
GERMANY: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 173
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 174
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 175
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 176
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 178
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 179
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 180
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 181
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 182
FRANCE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183
FRANCE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184
FRANCE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 186
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 187
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 188
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 190
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 191
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 194
UK: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195
UK: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196
UK: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 198
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 199
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 200
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 202
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 203
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 204
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 206
ITALY: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207
ITALY: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208
ITALY: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 210
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 211
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 212
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 213
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 214
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 215
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 218
SPAIN: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219
SPAIN: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220
SPAIN: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 222
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 223
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 224
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 226
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 227
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 229
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 230
REST OF EUROPE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231
REST OF EUROPE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232
REST OF EUROPE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 233
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 234
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 235
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 236
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 238
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 239
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 240
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 241
ASIA PACIFIC: KEY MACROINDICATORS
TABLE 242
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 243
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 244
ASIA PACIFIC: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 245
ASIA PACIFIC: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 246
ASIA PACIFIC: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 247
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 248
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 249
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 250
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 251
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 252
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 253
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 254
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 256
CHINA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 257
CHINA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 258
CHINA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 259
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 260
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 261
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 262
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 263
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 264
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 265
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 266
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 268
JAPAN: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 269
JAPAN: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270
JAPAN: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 271
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 272
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 273
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 274
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 275
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 276
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 277
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 279
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 280
INDIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281
INDIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 282
INDIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 283
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 284
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 285
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 286
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 288
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 289
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 290
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 291
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 292
SOUTH KOREA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 293
SOUTH KOREA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 294
SOUTH KOREA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 295
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 296
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 297
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 298
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 299
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 300
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 301
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 302
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 303
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 304
AUSTRALIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305
AUSTRALIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 306
AUSTRALIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 308
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 309
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 310
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 311
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 312
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 313
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 314
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 315
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 316
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 317
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 318
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 319
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 320
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 321
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 322
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 323
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 324
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 325
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 326
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 327
LATIN AMERICA: KEY MACROINDICATORS
TABLE 328
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 329
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 330
LATIN AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 331
LATIN AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 332
LATIN AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 333
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 334
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 335
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 336
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 337
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 338
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 339
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 340
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 341
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 342
BRAZIL: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 343
BRAZIL: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 344
BRAZIL: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 345
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 346
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 347
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 348
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 349
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 350
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 351
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 352
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 353
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 354
MEXICO: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 355
MEXICO: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 356
MEXICO: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 357
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 358
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 359
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 360
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 361
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 362
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 363
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 364
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 365
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 366
REST OF LATIN AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 367
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 368
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 369
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 370
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 371
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 372
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 373
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 374
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 375
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 376
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 377
MIDDLE EAST & AFRICA: KEY MACROINDICATORS
TABLE 378
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 379
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 380
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 381
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 382
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 383
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 384
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 385
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 386
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 387
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 388
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 389
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 390
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 391
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 392
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 393
GCC COUNTRIES: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 394
GCC COUNTRIES: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 395
GCC COUNTRIES: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 396
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 397
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 398
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 399
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 400
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 401
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 402
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 403
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 404
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 405
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 406
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 407
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 408
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 409
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 410
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 411
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 412
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 413
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 414
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 415
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 416
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 417
UAE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 418
UAE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 419
UAE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 420
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 421
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 422
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 423
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 424
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 425
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 426
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 427
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 428
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 429
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 430
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 431
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 432
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 433
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 434
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 435
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 436
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 437
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 438
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 439
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 440
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 441
SOUTH AFRICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 442
SOUTH AFRICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 443
SOUTH AFRICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 444
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 445
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 446
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 447
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 448
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 449
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 450
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 451
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 452
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 453
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 454
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 455
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 456
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
TABLE 457
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 458
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
TABLE 459
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 460
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
TABLE 461
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 462
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 463
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 464
OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, JANUARY 2022–FEBRUARY 2026
TABLE 465
PATIENT ENGAGEMENT SOLUTIONS MARKET: DEGREE OF COMPETITION
TABLE 466
PATIENT ENGAGEMENT SOLUTIONS MARKET: REGION FOOTPRINT
TABLE 467
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPONENT FOOTPRINT
TABLE 468
PATIENT ENGAGEMENT SOLUTIONS MARKET: APPLICATION FOOTPRINT
TABLE 469
PATIENT ENGAGEMENT SOLUTIONS MARKET: END-USER FOOTPRINT
TABLE 470
PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 471
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS/STARTUP PLAYERS, BY REGION
TABLE 472
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY COMPONENT
TABLE 473
PATIENT ENGAGEMENT SOLUTIONS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 474
PATIENT ENGAGEMENT SOLUTIONS MARKET: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 475
PATIENT ENGAGEMENT SOLUTIONS MARKET: EXPANSIONS, JANUARY 2022–FEBRUARY 2026
TABLE 476
PATIENT ENGAGEMENT SOLUTIONS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 477
MCKESSON CORPORATION: COMPANY OVERVIEW
TABLE 478
MCKESSON CORPORATION: PRODUCTS OFFERED
TABLE 479
MCKESSON CORPORATION: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 480
ORACLE: COMPANY OVERVIEW
TABLE 481
ORACLE: PRODUCTS OFFERED
TABLE 482
ORACLE: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2026
TABLE 483
ORACLE: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 484
MICROSOFT (NUANCE COMMUNICATIONS, INC.): COMPANY OVERVIEW
TABLE 485
MICROSOFT (NUANCE COMMUNICATIONS, INC.): PRODUCTS OFFERED
TABLE 486
MICROSOFT (NUANCE COMMUNICATIONS, INC.): PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2026
TABLE 487
MICROSOFT (NUANCE COMMUNICATIONS, INC.): DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 488
TRUBRIDGE: COMPANY OVERVIEW
TABLE 489
TRUBRIDGE: PRODUCTS OFFERED
TABLE 490
TRUBRIDGE: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 491
HEALTH CATALYST: COMPANY OVERVIEW
TABLE 492
HEALTH CATALYST: PRODUCTS OFFERED
TABLE 493
HEALTH CATALYST: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 494
VERADIGM LLC: COMPANY OVERVIEW
TABLE 495
VERADIGM LLC: PRODUCTS OFFERED
TABLE 496
VERADIGM LLC: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2026
TABLE 497
VERADIGM LLC: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 498
ATHENAHEALTH: COMPANY OVERVIEW
TABLE 499
ATHENAHEALTH: PRODUCTS OFFERED
TABLE 500
ATHENAHEALTH: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 501
ATHENAHEALTH: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 502
ATHENAHEALTH: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 503
GETWELLNETWORK, INC.: COMPANY OVERVIEW
TABLE 504
GETWELLNETWORK, INC.: PRODUCTS OFFERED
TABLE 505
GETWELLNETWORK, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 506
GETWELLNETWORK, INC.: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 507
LINCATA, INC.: COMPANY OVERVIEW
TABLE 508
LINCATA, INC.: PRODUCTS OFFERED
TABLE 509
COGNIZANT: COMPANY OVERVIEW
TABLE 510
COGNIZANT: PRODUCTS OFFERED
TABLE 511
COGNIZANT: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 512
ONEVIEW HEALTHCARE: COMPANY OVERVIEW
TABLE 513
ONEVIEW HEALTHCARE: PRODUCTS OFFERED
TABLE 514
ONEVIEW HEALTHCARE: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 515
ONEVIEW HEALTHCARE: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 516
ONEVIEW HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 517
ADVANCEDMD, INC.: COMPANY OVERVIEW
TABLE 518
ADVANCEDMD, INC.: PRODUCTS OFFERED
TABLE 519
ADVANCEDMD, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 520
ADVANCEDMD, INC.: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 521
EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 522
EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED
TABLE 523
EPIC SYSTEMS CORPORATION: PRODUCT ENHANCEMENT, JANUARY 2022–FEBRUARY 2026
TABLE 524
EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 525
HARRIS HEALTHCARE: COMPANY OVERVIEW
TABLE 526
HARRIS HEALTHCARE: PRODUCTS OFFERED
TABLE 527
HARRIS HEALTHCARE: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 528
MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 529
MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS OFFERED
TABLE 530
MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 531
MEDICAL INFORMATION TECHNOLOGY, INC.: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 532
TEBRA TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 533
TEBRA TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 534
TEBRA TECHNOLOGIES, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 535
TEBRA TECHNOLOGIES, INC.: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 536
TELEVOX: COMPANY OVERVIEW
TABLE 537
TELEVOX: PRODUCTS OFFERED
TABLE 538
TELEVOX: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2026
TABLE 539
TELEVOX: DEALS, JANUARY 2022–FEBRUARY 2026
TABLE 540
SOLUTIONREACH, INC.: COMPANY OVERVIEW
TABLE 541
SOLUTIONREACH, INC.: PRODUCTS OFFERED
TABLE 542
SOLUTIONREACH, INC.: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
TABLE 543
EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY OVERVIEW
TABLE 544
EXPERIAN INFORMATION SOLUTIONS, INC.: PRODUCTS OFFERED
TABLE 545
ECLINICALWORKS: COMPANY OVERVIEW
TABLE 546
ECLINICALWORKS: PRODUCTS OFFERED
TABLE 547
WELLSTACK: COMPANY OVERVIEW
TABLE 548
RELATIENT: COMPANY OVERVIEW
TABLE 549
LUMA HEALTH INC.: COMPANY OVERVIEW
TABLE 550
CIPHERHEALTH INC.: COMPANY OVERVIEW
TABLE 551
YOSI HEALTH: COMPANY OVERVIEW
TABLE 552
PATIENT ENGAGEMENT SOLUTIONS MARKET: STUDY ASSUMPTIONS
TABLE 553
PATIENT ENGAGEMENT SOLUTIONS MARKET: RISK ANALYSIS
FIGURE 1
PATIENT ENGAGEMENT SOLUTIONS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
PATIENT ENGAGEMENT SOLUTIONS MARKET: YEARS CONSIDERED
FIGURE 3
PATIENT ENGAGEMENT SOLUTIONS MARKET SCENARIO
FIGURE 4
GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, 2024–2031 (USD BILLION)
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022–2026
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 7
HIGH-GROWTH SEGMENTS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2026–2031
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PATIENT ENGAGEMENT SOLUTIONS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 9
GROWING ADOPTION OF TELEHEALTH AND REMOTE CARE TO DRIVE MARKET
FIGURE 10
ON-PREMISES AND US TO ACCOUNT FOR LARGEST NORTH AMERICAN PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE IN 2026
FIGURE 11
INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 12
PATIENT ENGAGEMENT SOLUTIONS MARKET DYNAMICS
FIGURE 13
PORTER’S FIVE FORCES ANALYSIS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 14
PATIENT ENGAGEMENT SOLUTIONS MARKET: VALUE CHAIN ANALYSIS
FIGURE 15
PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
FIGURE 16
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 17
FUNDING (USD MILLION) AND NUMBER OF DEALS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 18
PATENT PUBLICATION TRENDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2015–2025
FIGURE 19
JURISDICTION AND TOP APPLICANT ANALYSIS FOR PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 20
TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR PATIENT ENGAGEMENT SOLUTIONS MARKET (JANUARY 2015 TO DECEMBER 2025)
FIGURE 21
MARKET POTENTIAL OF AI/GEN AI ON PATIENT ENGAGEMENT SOLUTIONS ACROSS INDUSTRIES
FIGURE 22
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 23
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MAJOR END USERS
FIGURE 24
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 25
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIGURE 26
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIGURE 27
REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2020–2024 (USD MILLION)
FIGURE 28
MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2024)
FIGURE 29
PATIENT ENGAGEMENT SOLUTIONS MARKET: BRAND COMPARITIVE ANALYSIS
FIGURE 30
EV/EBITDA OF KEY VENDORS
FIGURE 31
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 32
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (2025)
FIGURE 33
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY FOOTPRINT
FIGURE 34
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 35
MCKESSON CORPORATION: COMPANY SNAPSHOT
FIGURE 36
ORACLE: COMPANY SNAPSHOT
FIGURE 37
MICROSOFT (NUANCE COMMUNICATIONS, INC.): COMPANY SNAPSHOT
FIGURE 38
TRUBRIDGE: COMPANY SNAPSHOT
FIGURE 39
HEALTH CATALYST: COMPANY SNAPSHOT
FIGURE 40
VERADIGM LLC: COMPANY SNAPSHOT
FIGURE 41
COGNIZANT: COMPANY SNAPSHOT
FIGURE 42
ONEVIEW HEALTHCARE: COMPANY SNAPSHOT
FIGURE 43
EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY SNAPSHOT
FIGURE 44
PATIENT ENGAGEMENT SOLUTIONS MARKET: RESEARCH DESIGN
FIGURE 45
PATIENT ENGAGEMENT SOLUTIONS MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 46
PATIENT ENGAGEMENT SOLUTIONS MARKET: KEY PRIMARY SOURCES
FIGURE 47
PATIENT ENGAGEMENT SOLUTIONS MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 48
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 49
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 50
PATIENT ENGAGEMENT SOLUTIONS MARKET: BOTTOM-UP APPROACH
FIGURE 51
PATIENT ENGAGEMENT SOLUTIONS MARKET: TOP-DOWN APPROACH
FIGURE 52
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 53
PATIENT ENGAGEMENT SOLUTIONS MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
FIGURE 54
PATIENT ENGAGEMENT SOLUTIONS MARKET: DATA TRIANGULATION METHODOLOGY
Ethan
Oct, 2022
What will be the value for the global Patient Engagement Solutions Market in 2030?.
Benjamin
Oct, 2022
Which of the geographical segment holds the major share of the Patient Engagement Solutions Market?.
Michael
Jun, 2026
After reviewing the Patient Engagement Solutions Market report, I gained a clearer understanding of how digital care coordination and remote monitoring platforms are influencing long-term patient retention strategies across healthcare systems..
William
Jun, 2026
I found the breakdown of patient engagement technologies and end-user adoption particularly useful for evaluating where healthcare providers are prioritizing investments in personalized communication and chronic care management..
David
Jun, 2026
The report helped me assess the competitive landscape of the Patient Engagement Solutions Market from an operational perspective, especially the growing role of mobile health applications and AI-enabled patient interaction tools..